We are live on !
Find out more
NQ HCIF GP Portfolio holdings
AUM
$50.2M
Turnover
0%
1-Year Est. Return
45.53%
This Fund
S&P 500
This Quarter Est. Return
+19.19%
1 Year Est. Return
-45.53%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$50.2M
AUM Growth
+$8.08M
(+19%)
Cap. Flow
$0
Cap. Flow % of AUM
Cap. Flow %
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
1.8
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
1.8
years
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
DELISTED
Revance Therapeutics, Inc.
RVNC
| $50.2M | 100% |
3,096,650
| – | – |
2014 Q4
7 quarters
|
|
Similar funds
HPA
CC
NQ HCIF GP's Q3 2016 Portfolio in Review
As of Q3 2016, NQ HCIF GP held 1 position worth $50.2M, up 19% from $42.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q3 2016: portfolio turnover was 0%. NQ HCIF GP opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- NQ HCIF GP's ten largest holdings make up 100% of its $50.2M portfolio in Q3 2016.
- NQ HCIF GP opened 0 new positions and closed 0 in Q3 2016.
- NQ HCIF GP's portfolio value rose 19% quarter-over-quarter to $50.2M.
Based on NQ HCIF GP's 13F filing for Q3 2016, filed 27 Oct 2016.